StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Scinai Immunotherapeutics's enterprise value was $247.41K on Nov 11, 2026, against $14.61M a year earlier. Over the last 5 years it ranged from $34.23K to $289.56M, with a median of $24.12M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$247.41K-97.5%
2025Dec 31, 2025$9.79M-60.7%
2024Dec 31, 2024$24.93M+76.4%
2023Dec 29, 2023$14.14M-53.6%
2022Dec 30, 2022$30.49M-87.8%
2021Dec 31, 2021$249.68M+20.7%
2020Dec 31, 2020$206.93M-65.9%
2019Dec 31, 2019$607.15M+177.1%
2018Dec 31, 2018$219.14M+24.2%
2017Dec 29, 2017$176.50M+99.7%
2016Dec 30, 2016$88.38M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?